Realtime | Geld | Brief | Zeit |
---|---|---|---|
42,350 | 42,710 | 02.07. | |
41,930 | 43,120 | 02.07. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
---|---|---|---|---|
Fr | Exas, Guardant, Gilead among gainers as Supreme Court ensures free preventive care | 4 | Seeking Alpha | |
20.06. | Guardant Health, Inc. - 8-K, Current Report | 2 | SEC Filings | |
09.06. | Guardant Health bei Goldman Sachs Konferenz: Strategische Wachstumseinblicke | 9 | Investing.com Deutsch | |
05.06. | Cathie Wood's ARK sells Palantir and Roblox, buys Veracyte and Guardant | 46 | Investing.com | |
04.06. | UBS analysts reiterate Buy rating for Guardant Health stock | 1 | Investing.com | |
GUARDANT HEALTH Aktie jetzt für 0€ handeln | ||||
04.06. | UBS-Analysten bekräftigen Kaufempfehlung für Guardant Health-Aktie | 11 | Investing.com Deutsch | |
04.06. | Why Guardant Health Stock Surged Nearly 9% Higher Today | 2 | The Motley Fool | |
03.06. | Guardant Health shares rise following FDA breakthrough designation | 4 | Investing.com | |
03.06. | Guardant Health gets FDA breakthrough device status for cancer detection test | 2 | Seeking Alpha | |
03.06. | Leerink Partners behält Outperform-Rating für Guardant Health-Aktie bei | 3 | Investing.com Deutsch | |
03.06. | Leerink Partners maintains outperform rating for Guardant Health stock | 1 | Investing.com | |
03.06. | Cathie Wood's ARK buys Guardant Health, sells Adaptive Biotechnologies stock | 6 | Investing.com | |
02.06. | Raymond James reaffirms Guardant Health stock rating after NCCN update | 6 | Investing.com | |
02.06. | Raymond James bestätigt Guardant Health-Bewertung nach NCCN-Update | 9 | Investing.com Deutsch | |
01.06. | Guardant Health, Inc. (GH)'s ctDNA Test Predicts Colon Cancer Recurrence Risk in Stage III Patients | 1 | Insider Monkey | |
27.05. | Guardant Health enhances cancer blood test capabilities | 2 | Investing.com | |
27.05. | Guardant Health verbessert Bluttest-Fähigkeiten zur Krebserkennung | 1 | Investing.com Deutsch | |
21.05. | Guardant Health expands oncology testing with IHC suite | 2 | Investing.com | |
21.05. | Guardant Health erweitert onkologische Tests mit IHC-Suite | 4 | Investing.com Deutsch | |
20.05. | Guardant Health stellt neuen Krebsrisiko-Test vor | 3 | Investing.com Deutsch |